SOAPware Learning CenterClinical Quality Measures User Guide (for 2011) Additional Measures (Choose 3 Additional Measures)NQF 0074 (Additional): Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL-Cholesterol

NQF 0074 (Additional): Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL-Cholesterol

Measure: NQF 0074 (Additional Measure)

Measure Title: Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL-Cholesterol

Measurement Description: Percentage of patients aged 18 years and older with a diagnosis of CAD who were prescribed a lipid-lowering therapy (based on current ACC/AHA guidelines).

*REQUIRED FOR MEANINGFUL USE (MU): Click here to view the Meaningful Use Criteria.

Quality Measure Documentation Workflow

Quality Measure Documentation Workflow

1.  The patient must be 18 years of age or older and have at least one face-to-face encounter with the provider during the reporting period.

2.  Patients must have a diagnosis of Coronary Artery Disease (CAD) documented in the Summary Active Problems or the Assessment field of the encounter using one of the following ICD codes:

410.00, 410.01, 410.02, 410.10, 410.11, 410.12, 410.20, 410.21, 410.22, 410.30, 410.31, 410.32, 410.40, 410.41, 410.42, 410.50, 410.51, 410.52, 410.60, 410.61, 410.62, 410.70, 410.71, 410.72, 410.80, 410.81,     410.82, 410.90, 410.91, 410.92, 411.0, 411.1, 411.81, 411.89, 412, 413.0, 413.1, 413.9, 414.00, 414.01, 414.02, 414.03, 414.04, 414.05, 414.06, 414.07, 414.8, 414.9, V45.81, V45.82.

3.  Documentation that a lipid-lowering therapy (based on current ACC/AHA guidelines) was prescribed by entering one of the following medications into the encounter Medications or Summary Medications field:

Lipitor, Crestor, Lofibra, Lovastatin, Lovasa, Pravastatin,  Questran, Simvastatin, Tricor,  Vytorin, Welchol, Zetia.

Measure Calculation Details

Numerator Calculation:

The numerator for this measure is calculated based on the following:

1.  The number of patients in the denominator that had a lipid-lowering therapy (based on current ACC/AHA guidelines) prescribed by entering one of the following medications into the encounter Medications or Summary Medications field:

  • Lipitor: d04105
  • Crestor: d048510074-3
  • Lofibra: d04286
  • Lovastatin: d00280
  • Lovasa: d00497
  • Pravastatin: d00348
  • Questran: d00193
  • Simvastatin: d00746
  • Tricor: d04286
  • Vytorin: d05348
  • Welchol: d04695
  • Zetia: d04824

Denominator:

The denominator for this measure is calculated based on the following:

1.  The number of patients 18 or older at the start of the reporting period and have at least one face-to-face encounter with the provider during the reporting period;

2.  And have a diagnosis of Coronary Artery Disease documented in the Summary Active Problems or the encounter Assessment field. This can be accomplished by documentation of one of the following ICD codes:

  • 410.00, 410.01, 410.02, 410.10, 410.11, 410.12, 410.20, 410.21, 410.22, 410.30, 410.31, 410.32, 410.40, 410.41, 410.42, 410.50, 410.51, 410.52, 410.60, 410.61, 410.62, 410.70, 410.71, 410.72, 410.80, 410.81, 410.82, 410.90, 410.91, 410.92, 411.0, 411.1, 411.81, 411.89, 412, 413.0, 413.1, 413.9, 414.00, 414.01, 414.02, 414.03, 414.04, 414.05, 414.06, 414.07, 414.8, 414.9, V45.81, V45.82.

Report Clinical Quality Measures to CMS/States

All of the items in the above steps need to be documented as structured data (as detailed above) in order to allow the user to capture the numerator, denominator and percentage for this quality measure.

For more information on how to export the numerator, denominator, and percentage for each Clinical Quality measure, Click Here.

For more information on reporting clinical quality measures, Click Here.